These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21478162)

  • 1. Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.
    Lamon-Fava S; Marcovina SM; Albers JJ; Kennedy H; DeLuca C; White CC; Cupples LA; McNamara JR; Seman LJ; Bongard V; Schaefer EJ
    J Lipid Res; 2011 Jun; 52(6):1181-1187. PubMed ID: 21478162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
    Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD
    J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population.
    Paultre F; Tuck CH; Boden-Albala B; Kargman DE; Todd E; Jones J; Paik MC; Sacco RL; Berglund L
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):141-6. PubMed ID: 11788474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
    Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
    Hopewell JC; Seedorf U; Farrall M; Parish S; Kyriakou T; Goel A; Hamsten A; Collins R; Watkins H; Clarke R;
    J Intern Med; 2014 Sep; 276(3):260-8. PubMed ID: 24372611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.